Filing Details
- Accession Number:
- 0001127602-25-013484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-06 16:40:24
- Reporting Period:
- 2025-05-02
- Filing Date:
- 2025-05-06
- Accepted Time:
- 2025-05-06 16:40:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1891344 | Nancy Valente | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | Evp, Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-02 | 4,616 | $11.03 | 49,169 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 13,099 restricted stock units.